SCHEMBL4214741

SCHEMBL4214741

CCCC(=O)NOc1ccc(C(=O)OCc2ccccc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.57
RAB9A P51151 3/20 0.57
GAA P10253 1/20 0.57
TDP1 Q9NUW8 4/20 0.55
SLC6A2 P23975 1/20 0.55
SLC6A3 Q01959 1/20 0.55
LMNA P02545 2/20 0.55
MAPT P10636 3/20 0.52
ALDH1A1 P00352 2/20 0.52
HPGD P15428 1/20 0.52
L3MBTL1 Q9Y468 3/20 0.48
CYP3A4 P08684 2/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.46
HDAC3 O15379 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
NCOR2 Q9Y618 1/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3857282 0.80 ALOX5 (0.51) RAB9AGAAMAPTALDH1A1HPGD
SCHEMBL4216357 0.80 ALDH1A1 (0.54) KMT2ARAB9AGAATDP1SLC6A2
SCHEMBL4216365 0.80 ALDH1A1 (0.54) KMT2ARAB9AGAATDP1SLC6A2
SCHEMBL20830910 0.77 TSHR (0.65) KMT2ARAB9AGAATDP1SLC6A2
SCHEMBL13481158 0.77 KMT2A (0.63) KMT2ARAB9AGAATDP1SLC6A2
SCHEMBL312287 0.77 KMT2A (0.92) KMT2ARAB9AGAATDP1SLC6A2
SCHEMBL20830918 0.76 KMT2A (0.67) KMT2ARAB9AGAATDP1SLC6A2
SCHEMBL11416620 0.76 TSHR (0.78) KMT2ARAB9AGAATDP1SLC6A2
SCHEMBL2704247 0.76 KMT2A (0.71) KMT2ARAB9AGAATDP1SLC6A2
Benzyl Benzoate SCHEMBL9058384 0.76 TDP1 (0.82) KMT2ARAB9AGAATDP1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054629-A1 Inhibitors of Transthyretin Amyloid Fibril Formation THE SCRIPPS RESEARCH INSTITUTE (US) 2009-02-26 US disclosed
US-7312361-B2 Inhibitors of transthyretin amyloid fibril formation THE SCRIPPS RESEARCH INSTITUTE (US) 2007-12-25 US disclosed
US-20060178527-A1 Inhibitors of transthyretin amyloid fibril formation THE SCRIPPS RESEARCH INSTITUTE (US) 2006-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054629-A1 Inhibitors of Transthyretin Amyloid Fibril Formation TTR, TTPA, APOB KMT2A 3558/4885RAB9A 3490/4885GAA 1261/4885
US-20060178527-A1 Inhibitors of transthyretin amyloid fibril formation TTR, TTPA, APOB KMT2A 3558/4885RAB9A 3490/4885GAA 1261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.